Entry - #275900 - SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20 - OMIM
# 275900

SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20


Alternative titles; symbols

TROYER SYNDROME
SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING
SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
13q13.3 Troyer syndrome 275900 AR 3 SPART 607111
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Height
- Short stature
HEAD & NECK
Face
- Overgrowth of the maxilla
Eyes
- Hypertelorism
Mouth
- Tongue dyspraxia
SKELETAL
Spine
- Kyphoscoliosis
Limbs
- Contractures
Hands
- Hyperextensible hand joints
- Brachydactyly
- Clinodactyly
- Camptodactyly
Feet
- Pes cavus
- Hammertoes
- Small feet
MUSCLE, SOFT TISSUES
- Distal amyotrophy, especially of hands and feet
NEUROLOGIC
Central Nervous System
- Delayed motor development
- Delayed cognitive development
- Lower limb spasticity
- Lower limb weakness
- Upper limb spasticity
- Spastic gait
- Walking difficulties
- Hyperreflexia
- Dysmetria
- Knee and ankle clonus
- Extensor plantar responses
- Dysarthria
- Drooling
- Cerebellar signs
- Cerebellar atrophy
- Periventricular white matter changes
Behavioral Psychiatric Manifestations
- Emotional lability (variable)
MISCELLANEOUS
- Onset in early childhood
- Genetic heterogeneity, see SPG5A (270800) for overview of recessive SPGs
MOLECULAR BASIS
- Caused by mutation in the spartin gene (SPG20, 607111.0001)
Spastic paraplegia - PS303350 - 86 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.13 Spastic paraplegia 78, autosomal recessive AR 3 617225 ATP13A2 610513
1p34.1 Spastic paraplegia 83, autosomal recessive AR 3 619027 HPDL 618994
1p31.1-p21.1 Spastic paraplegia 29, autosomal dominant AD 2 609727 SPG29 609727
1p13.3 ?Spastic paraplegia 63, autosomal recessive AR 3 615686 AMPD2 102771
1p13.2 Spastic paraplegia 47, autosomal recessive AR 3 614066 AP4B1 607245
1q32.1 Spastic paraplegia 23, autosomal recessive AR 3 270750 DSTYK 612666
1q42.13 ?Spastic paraplegia 44, autosomal recessive AR 3 613206 GJC2 608803
1q42.13 ?Spastic paraplegia 74, autosomal recessive AR 3 616451 IBA57 615316
2p23.3 Spastic paraplegia 81, autosomal recessive AR 3 618768 SELENOI 607915
2p22.3 Spastic paraplegia 4, autosomal dominant AD 3 182601 SPAST 604277
2p13.3 Spastic paraplegia 93, autosomal recessive AR 3 620938 NFU1 608100
2p11.2 Spastic paraplegia 31, autosomal dominant AD 3 610250 REEP1 609139
2q33.1 Spastic paraplegia 13, autosomal dominant AD 3 605280 HSPD1 118190
2q37.3 Spastic paraplegia 30, autosomal dominant AD 3 610357 KIF1A 601255
2q37.3 Spastic paraplegia 30, autosomal recessive AR 3 620607 KIF1A 601255
3q12.2 ?Spastic paraplegia 57, autosomal recessive AR 3 615658 TFG 602498
3q25.31 Spastic paraplegia 42, autosomal dominant AD 3 612539 SLC33A1 603690
3q27-q28 Spastic paraplegia 14, autosomal recessive AR 2 605229 SPG14 605229
4p16-p15 Spastic paraplegia 38, autosomal dominant AD 2 612335 SPG38 612335
4p13 Spastic paraplegia 79A, autosomal dominant AD 3 620221 UCHL1 191342
4p13 Spastic paraplegia 79B, autosomal recessive AR 3 615491 UCHL1 191342
4q25 Spastic paraplegia 56, autosomal recessive AR 3 615030 CYP2U1 610670
5q31.2 Spastic paraplegia 72A, autosomal dominant AD 3 615625 REEP2 609347
5q31.2 ?Spastic paraplegia 72B, autosomal recessive AR 3 620606 REEP2 609347
6p25.1 Spastic paraplegia 77, autosomal recessive AR 3 617046 FARS2 611592
6p21.33 Spastic paraplegia 86, autosomal recessive AR 3 619735 ABHD16A 142620
6q23-q24.1 Spastic paraplegia 25, autosomal recessive AR 2 608220 SPG25 608220
7p22.1 Spastic paraplegia 48, autosomal recessive AR 3 613647 AP5Z1 613653
7q22.1 Spastic paraplegia 50, autosomal recessive AR 3 612936 AP4M1 602296
8p22 Spastic paraplegia 53, autosomal recessive AR 3 614898 VPS37A 609927
8p21.1-q13.3 Spastic paraplegia 37, autosomal dominant AD 2 611945 SPG37 611945
8p11.23 Spastic paraplegia 18A, autosomal dominant AD 3 620512 ERLIN2 611605
8p11.23 Spastic paraplegia 18B, autosomal recessive AR 3 611225 ERLIN2 611605
8p11.23 Spastic paraplegia 54, autosomal recessive AR 3 615033 DDHD2 615003
8p11.21 Spastic paraplegia 85, autosomal recessive AR 3 619686 RNF170 614649
8q12.3 Spastic paraplegia 5A, autosomal recessive AR 3 270800 CYP7B1 603711
8q24.13 Spastic paraplegia 8, autosomal dominant AD 3 603563 WASHC5 610657
9p13.3 Spastic paraplegia 46, autosomal recessive AR 3 614409 GBA2 609471
9q Spastic paraplegia 19, autosomal dominant AD 2 607152 SPG19 607152
9q34.11 Spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia AD 3 620538 SPTAN1 182810
10q22.1-q24.1 Spastic paraplegia 27, autosomal recessive AR 2 609041 SPG27 609041
10q24.1 Spastic paraplegia 9B, autosomal recessive AR 3 616586 ALDH18A1 138250
10q24.1 Spastic paraplegia 9A, autosomal dominant AD 3 601162 ALDH18A1 138250
10q24.1 Spastic paraplegia 64, autosomal recessive AR 3 615683 ENTPD1 601752
10q24.31 Spastic paraplegia 62, autosomal recessive AR 3 615681 ERLIN1 611604
10q24.32-q24.33 Spastic paraplegia 45, autosomal recessive AR 3 613162 NT5C2 600417
11p14.1-p11.2 ?Spastic paraplegia 41, autosomal dominant AD 2 613364 SPG41 613364
11q12.3 Silver spastic paraplegia syndrome AD 3 270685 BSCL2 606158
11q13.1 Spastic paraplegia 76, autosomal recessive AR 3 616907 CAPN1 114220
12q13.3 Spastic paraplegia 70, autosomal recessive AR 3 620323 MARS1 156560
12q13.3 Spastic paraplegia 10, autosomal dominant AD 3 604187 KIF5A 602821
12q13.3 Spastic paraplegia 26, autosomal recessive AR 3 609195 B4GALNT1 601873
12q23-q24 Spastic paraplegia 36, autosomal dominant AD 2 613096 SPG36 613096
12q23.3 Spastic paraplegia 92, autosomal recessive AR 3 620911 FICD 620875
12q24.31 Spastic paraplegia 55, autosomal recessive AR 3 615035 MTRFR 613541
13q13.3 Troyer syndrome AR 3 275900 SPART 607111
13q14 Spastic paraplegia 24, autosomal recessive AR 2 607584 SPG24 607584
13q14.2 Spastic paraplegia 88, autosomal dominant AD 3 620106 KPNA3 601892
14q12-q21 Spastic paraplegia 32, autosomal recessive AR 2 611252 SPG32 611252
14q12 Spastic paraplegia 52, autosomal recessive AR 3 614067 AP4S1 607243
14q13.1 ?Spastic paraplegia 90B, autosomal recessive AD 3 620417 SPTSSA 613540
14q13.1 Spastic paraplegia 90A, autosomal dominant AD 3 620416 SPTSSA 613540
14q22.1 Spastic paraplegia 3A, autosomal dominant AD 3 182600 ATL1 606439
14q22.1 Spastic paraplegia 28, autosomal recessive AR 3 609340 DDHD1 614603
14q24.1 Spastic paraplegia 15, autosomal recessive AR 3 270700 ZFYVE26 612012
14q24.3 Spastic paraplegia 87, autosomal recessive AR 3 619966 TMEM63C 619953
15q11.2 Spastic paraplegia 6, autosomal dominant AD 3 600363 NIPA1 608145
15q21.1 Spastic paraplegia 11, autosomal recessive AR 3 604360 SPG11 610844
15q21.2 Spastic paraplegia 51, autosomal recessive AR 3 613744 AP4E1 607244
15q22.31 Mast syndrome AR 3 248900 ACP33 608181
16p12.3 Spastic paraplegia 61, autosomal recessive AR 3 615685 ARL6IP1 607669
16q13 Spastic paraplegia 89, autosomal recessive AR 3 620379 AMFR 603243
16q23.1 Spastic paraplegia 35, autosomal recessive AR 3 612319 FA2H 611026
16q24.3 Spastic paraplegia 7, autosomal recessive AD, AR 3 607259 PGN 602783
17q25.3 Spastic paraplegia 82, autosomal recessive AR 3 618770 PCYT2 602679
19p13.2 Spastic paraplegia 39, autosomal recessive AR 3 612020 PNPLA6 603197
19q12 ?Spastic paraplegia 43, autosomal recessive AR 3 615043 C19orf12 614297
19q13.12 Spastic paraplegia 75, autosomal recessive AR 3 616680 MAG 159460
19q13.32 Spastic paraplegia 12, autosomal dominant AD 3 604805 RTN2 603183
19q13.33 ?Spastic paraplegia 73, autosomal dominant AD 3 616282 CPT1C 608846
22q11.21 Spastic paraplegia 84, autosomal recessive AR 3 619621 PI4KA 600286
Xq11.2 Spastic paraplegia 16, X-linked, complicated XLR 2 300266 SPG16 300266
Xq22.2 Spastic paraplegia 2, X-linked XLR 3 312920 PLP1 300401
Xq24-q25 Spastic paraplegia 34, X-linked XLR 2 300750 SPG34 300750
Xq28 MASA syndrome XLR 3 303350 L1CAM 308840
Not Mapped Spastic paraplegia 33, autosomal dominant AD 610244 SPG33 610244

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive spastic paraplegia-20, also known as Troyer syndrome, is caused by homozygous mutation in the SPG20 gene, encoding spartin (607111), on chromosome 13q13. SPG20 is a form of complicated SPG.

For a discussion of genetic heterogeneity of autosomal recessive SPG, see SPG5A (270800).


Clinical Features

In an Amish group in Ohio, Cross and McKusick (1967) observed 20 cases of spastic paraplegia with distal muscle wasting, and designated it Troyer syndrome for the surname of many of the affected persons. The disorder has its onset in early childhood with dysarthria, distal muscle wasting, and difficulty in learning to walk. Lower limb spasticity and contractures usually make walking impossible by the third or fourth decade. Drooling and mild cerebellar signs occur in some. All have weakness and atrophy of thenar, hypothenar, and dorsal interosseous muscles.

Bakowska et al. (2008) reported an Amish brother and sister from Ohio with Troyer syndrome. Both showed delayed motor and cognitive development and developed a progressive deterioration in gait and speech during childhood. Physical exam showed short stature, spastic dysarthria, mild pyramidal weakness in the lower extremities, distal amyotrophy, and hyperreflexia of the lower limbs. Skeletal examination in both sibs was notable for kyphoscoliosis, loss of teeth, pes cavus, small feet, and hyperextensible joints of the hands. The brother had severe pectus excavatum. Gait was wide-based and spastic; the brother ambulated with difficulty and required assistance, whereas the sister was wheelchair-bound. Both had occasional inappropriate euphoria or crying, consistent with emotional lability.

Manzini et al. (2010) reported a large Omani kindred with SPG20. All affected individuals presented with short stature and dysarthria, and showed delayed motor and cognitive development. The main features included spastic gait, hyperreflexia, and dysmetria of the upper limbs. Other findings included hypertelorism, overgrowth of the maxilla, brachydactyly, clinodactyly, camptodactyly, pes cavus, tightening of the heel cords, hammer toes, and ankle clonus. Brain MRI showed atrophy of the cerebellar vermis, mild white matter volume loss, and periventricular white matter changes suggestive of gliosis. Although the patients were young, there appeared to be progression of the disorder.

Tawamie et al. (2015) reported 2 sibs, born of consanguineous Turkish parents, with complicated spastic paraplegia. The patients were 26 and 17 years of age at the time of the report. The older sister had delayed psychomotor development in infancy. At age 5 years, she had overall growth retardation, generalized hypotonia, and joint hypermobility. As a teenager and young adult, she had muscle weakness and atrophy of the upper extremities, hoarse voice, high-arched feet, and hyperreflexia of the lower limbs. Skeletal abnormalities included low-set dysmorphic thumbs and clinodactyly with mild skeletal abnormalities of the hand. She developed psychiatric disturbances, including anxiety, panic attacks, hallucinations, psychosis, and suicidal ideation; her IQ was 46. Her brother had developmental delay, overall growth retardation, hypotonia with muscle atrophy, hyperextensible joints, ataxic gait, and slurred speech. Both patients had mild dysmorphic features, including prominent nose, raised nostrils, epicanthus, downslanting palpebral fissures, and low-set ears.

Butler et al. (2016) reported 2 sisters and an unrelated boy, all of Filipino descent, with SPG20. The patients had short stature, failure to thrive with poor overall growth and small head circumference, and mildly delayed development with variable learning difficulties and speech delay. All had an unsteady unbalanced gait, but only the sisters showed frank spasticity and inturned ankles. Additional features included mild proximal weakness, distal amyotrophy, dystonic posturing of the hands, and ankle contractures, as well as dysarthria and oromotor dysfunction. Dysmorphic features were mild, but included microcephaly, frontal bossing, flat midface, narrow mandible, upturned nostrils, and posterior rotation of the ears. All patients attended school; 2 were in special needs classes.


Inheritance

The transmission pattern of SPG20 in the families reported by Bakowska et al. (2008) was consistent with autosomal recessive inheritance.


Mapping

Patel et al. (2002) excluded 5 loci for autosomal recessive hereditary spastic paraplegia by linkage analysis and, using homozygosity mapping, mapped the Troyer syndrome gene to a 731-kb interval of chromosome 13q12.3. All affected individuals were homozygous for this segment. A maximum location score of 19.6 was obtained between markers D13S1841 and D13S1842.


Molecular Genetics

Patel et al. (2002) identified a frameshift mutation (1110delA; 607111.0001) in the SPG20 gene in individuals with Troyer syndrome from the Amish kindred in which the disorder was first described.

Bakowska et al. (2008) identified the 1110delA mutation in 2 Amish sibs with Troyer syndrome. Studies on patient fibroblasts and lymphoblasts showed spartin mRNA transcripts, but no translated protein, consistent with complete loss of function.

In affected members of a large Omani kindred with SPG20, Manzini et al. (2010) identified a homozygous truncating mutation in the SPG20 gene (364_365delAT; 607111.0002).

In 2 sibs, born of consanguineous Turkish parents, with SPG20, Tawamie et al. (2015) identified homozygosity for the same truncating mutation in the SPG20 gene (607111.0002) that had been identified in Omani patients by Manzini et al. (2010). The mutation, which was found by a combination of homozygosity mapping and whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Functional studies and studies of patient cells were not performed. Haplotype analysis indicated that the mutation occurred independently from that in the Omani patients reported by Manzini et al. (2010).

In 3 patients of Filipino descent, including 2 sisters, Butler et al. (2016) also identified homozygosity for the previously reported c.364_365delAT frameshift mutation (607111.0002) in the SPG20 gene. The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the families. Functional studies of the variant and studies of patient cells were not performed, but the occurrence of the same mutation in 3 families of different ethnicities confirmed the pathogenicity.

Associations Pending Confirmation

For discussion of a possible role of the GRID2 gene in the Troyer syndrome phenotype, see 602368.


See Also:

REFERENCES

  1. Bakowska, J. C., Wang, H., Xin, B., Sumner, C. J., Blackstone, C. Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism? Arch. Neurol. 65: 520-524, 2008. [PubMed: 18413476, related citations] [Full Text]

  2. Butler, S., Helbig, K. L., Alcaraz, W., Seaver, L. H., Hsieh, D. T., Rohena, L. Three cases of Troyer syndrome in two families of Filipino descent. Am. J. Med. Genet. 170A: 1780-1785, 2016. [PubMed: 27112432, related citations] [Full Text]

  3. Cross, H. E., McKusick, V. A. The Troyer syndrome: a recessive form of spastic paraplegia with distal muscle wasting. Arch. Neurol. 16: 473-485, 1967. [PubMed: 6022528, related citations] [Full Text]

  4. Manzini, M. C., Rajab, A., Maynard, T. M., Mochida, G. H., Tan, W.-H., Nasir, R., Hill, R. S., Gleason, D., Al Saffar, M., Partlow, J. N., Barry, B. J., Vernon, M., LaMantia, A.-S., Walsh, C. A. Developmental and degenerative features in a complicated spastic paraplegia. Ann. Neurol. 67: 516-525, 2010. [PubMed: 20437587, images, related citations] [Full Text]

  5. Neuhauser, G., Wiffler, C., Opitz, J. M. Familial spastic paraplegia with distal muscle wasting in the Old Order Amish: atypical Troyer syndrome or 'new' syndrome. Clin. Genet. 9: 315-323, 1976. [PubMed: 1261070, related citations] [Full Text]

  6. Patel, H., Cross, H., Proukakis, C., Hershberger, R., Bork, P., Ciccarelli, F. D., Patton, M. A., McKusick, V. A., Crosby, A. H. SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nature Genet. 31: 347-348, 2002. [PubMed: 12134148, related citations] [Full Text]

  7. Tawamie, H., Wohlleber, E., Uebe, S., Schmal, C., Nothen, M. M., Jamra, R. A. Recurrent null mutation in SPG20 leads to Troyer syndrome. Molec. Cell. Probes 29: 315-318, 2015. [PubMed: 26003402, related citations] [Full Text]


Cassandra L. Kniffin - updated : 03/01/2018
Cassandra L. Kniffin - updated : 5/11/2016
Cassandra L. Kniffin - updated : 6/25/2010
Cassandra L. Kniffin - updated : 1/7/2009
Victor A. McKusick - updated : 7/23/2002
Creation Date:
Victor A. McKusick : 6/4/1986
carol : 03/06/2018
carol : 03/05/2018
ckniffin : 03/01/2018
alopez : 05/16/2016
ckniffin : 5/11/2016
alopez : 4/2/2014
wwang : 6/29/2010
ckniffin : 6/25/2010
wwang : 1/13/2009
ckniffin : 1/7/2009
ckniffin : 10/1/2008
ckniffin : 2/8/2005
carol : 9/18/2002
tkritzer : 9/11/2002
tkritzer : 9/11/2002
alopez : 8/1/2002
mgross : 7/24/2002
terry : 7/23/2002
terry : 7/23/2002
carol : 1/3/1995
mimadm : 3/12/1994
carol : 4/22/1992
supermim : 3/17/1992
carol : 3/2/1992
supermim : 3/20/1990

# 275900

SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20


Alternative titles; symbols

TROYER SYNDROME
SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING
SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE


SNOMEDCT: 230264003;   ORPHA: 101000;   DO: 0050886;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
13q13.3 Troyer syndrome 275900 Autosomal recessive 3 SPART 607111

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive spastic paraplegia-20, also known as Troyer syndrome, is caused by homozygous mutation in the SPG20 gene, encoding spartin (607111), on chromosome 13q13. SPG20 is a form of complicated SPG.

For a discussion of genetic heterogeneity of autosomal recessive SPG, see SPG5A (270800).


Clinical Features

In an Amish group in Ohio, Cross and McKusick (1967) observed 20 cases of spastic paraplegia with distal muscle wasting, and designated it Troyer syndrome for the surname of many of the affected persons. The disorder has its onset in early childhood with dysarthria, distal muscle wasting, and difficulty in learning to walk. Lower limb spasticity and contractures usually make walking impossible by the third or fourth decade. Drooling and mild cerebellar signs occur in some. All have weakness and atrophy of thenar, hypothenar, and dorsal interosseous muscles.

Bakowska et al. (2008) reported an Amish brother and sister from Ohio with Troyer syndrome. Both showed delayed motor and cognitive development and developed a progressive deterioration in gait and speech during childhood. Physical exam showed short stature, spastic dysarthria, mild pyramidal weakness in the lower extremities, distal amyotrophy, and hyperreflexia of the lower limbs. Skeletal examination in both sibs was notable for kyphoscoliosis, loss of teeth, pes cavus, small feet, and hyperextensible joints of the hands. The brother had severe pectus excavatum. Gait was wide-based and spastic; the brother ambulated with difficulty and required assistance, whereas the sister was wheelchair-bound. Both had occasional inappropriate euphoria or crying, consistent with emotional lability.

Manzini et al. (2010) reported a large Omani kindred with SPG20. All affected individuals presented with short stature and dysarthria, and showed delayed motor and cognitive development. The main features included spastic gait, hyperreflexia, and dysmetria of the upper limbs. Other findings included hypertelorism, overgrowth of the maxilla, brachydactyly, clinodactyly, camptodactyly, pes cavus, tightening of the heel cords, hammer toes, and ankle clonus. Brain MRI showed atrophy of the cerebellar vermis, mild white matter volume loss, and periventricular white matter changes suggestive of gliosis. Although the patients were young, there appeared to be progression of the disorder.

Tawamie et al. (2015) reported 2 sibs, born of consanguineous Turkish parents, with complicated spastic paraplegia. The patients were 26 and 17 years of age at the time of the report. The older sister had delayed psychomotor development in infancy. At age 5 years, she had overall growth retardation, generalized hypotonia, and joint hypermobility. As a teenager and young adult, she had muscle weakness and atrophy of the upper extremities, hoarse voice, high-arched feet, and hyperreflexia of the lower limbs. Skeletal abnormalities included low-set dysmorphic thumbs and clinodactyly with mild skeletal abnormalities of the hand. She developed psychiatric disturbances, including anxiety, panic attacks, hallucinations, psychosis, and suicidal ideation; her IQ was 46. Her brother had developmental delay, overall growth retardation, hypotonia with muscle atrophy, hyperextensible joints, ataxic gait, and slurred speech. Both patients had mild dysmorphic features, including prominent nose, raised nostrils, epicanthus, downslanting palpebral fissures, and low-set ears.

Butler et al. (2016) reported 2 sisters and an unrelated boy, all of Filipino descent, with SPG20. The patients had short stature, failure to thrive with poor overall growth and small head circumference, and mildly delayed development with variable learning difficulties and speech delay. All had an unsteady unbalanced gait, but only the sisters showed frank spasticity and inturned ankles. Additional features included mild proximal weakness, distal amyotrophy, dystonic posturing of the hands, and ankle contractures, as well as dysarthria and oromotor dysfunction. Dysmorphic features were mild, but included microcephaly, frontal bossing, flat midface, narrow mandible, upturned nostrils, and posterior rotation of the ears. All patients attended school; 2 were in special needs classes.


Inheritance

The transmission pattern of SPG20 in the families reported by Bakowska et al. (2008) was consistent with autosomal recessive inheritance.


Mapping

Patel et al. (2002) excluded 5 loci for autosomal recessive hereditary spastic paraplegia by linkage analysis and, using homozygosity mapping, mapped the Troyer syndrome gene to a 731-kb interval of chromosome 13q12.3. All affected individuals were homozygous for this segment. A maximum location score of 19.6 was obtained between markers D13S1841 and D13S1842.


Molecular Genetics

Patel et al. (2002) identified a frameshift mutation (1110delA; 607111.0001) in the SPG20 gene in individuals with Troyer syndrome from the Amish kindred in which the disorder was first described.

Bakowska et al. (2008) identified the 1110delA mutation in 2 Amish sibs with Troyer syndrome. Studies on patient fibroblasts and lymphoblasts showed spartin mRNA transcripts, but no translated protein, consistent with complete loss of function.

In affected members of a large Omani kindred with SPG20, Manzini et al. (2010) identified a homozygous truncating mutation in the SPG20 gene (364_365delAT; 607111.0002).

In 2 sibs, born of consanguineous Turkish parents, with SPG20, Tawamie et al. (2015) identified homozygosity for the same truncating mutation in the SPG20 gene (607111.0002) that had been identified in Omani patients by Manzini et al. (2010). The mutation, which was found by a combination of homozygosity mapping and whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Functional studies and studies of patient cells were not performed. Haplotype analysis indicated that the mutation occurred independently from that in the Omani patients reported by Manzini et al. (2010).

In 3 patients of Filipino descent, including 2 sisters, Butler et al. (2016) also identified homozygosity for the previously reported c.364_365delAT frameshift mutation (607111.0002) in the SPG20 gene. The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the families. Functional studies of the variant and studies of patient cells were not performed, but the occurrence of the same mutation in 3 families of different ethnicities confirmed the pathogenicity.

Associations Pending Confirmation

For discussion of a possible role of the GRID2 gene in the Troyer syndrome phenotype, see 602368.


See Also:

Neuhauser et al. (1976)

REFERENCES

  1. Bakowska, J. C., Wang, H., Xin, B., Sumner, C. J., Blackstone, C. Lack of spartin protein in Troyer syndrome: a loss-of-function disease mechanism? Arch. Neurol. 65: 520-524, 2008. [PubMed: 18413476] [Full Text: https://doi.org/10.1001/archneur.65.4.520]

  2. Butler, S., Helbig, K. L., Alcaraz, W., Seaver, L. H., Hsieh, D. T., Rohena, L. Three cases of Troyer syndrome in two families of Filipino descent. Am. J. Med. Genet. 170A: 1780-1785, 2016. [PubMed: 27112432] [Full Text: https://doi.org/10.1002/ajmg.a.37658]

  3. Cross, H. E., McKusick, V. A. The Troyer syndrome: a recessive form of spastic paraplegia with distal muscle wasting. Arch. Neurol. 16: 473-485, 1967. [PubMed: 6022528] [Full Text: https://doi.org/10.1001/archneur.1967.00470230025003]

  4. Manzini, M. C., Rajab, A., Maynard, T. M., Mochida, G. H., Tan, W.-H., Nasir, R., Hill, R. S., Gleason, D., Al Saffar, M., Partlow, J. N., Barry, B. J., Vernon, M., LaMantia, A.-S., Walsh, C. A. Developmental and degenerative features in a complicated spastic paraplegia. Ann. Neurol. 67: 516-525, 2010. [PubMed: 20437587] [Full Text: https://doi.org/10.1002/ana.21923]

  5. Neuhauser, G., Wiffler, C., Opitz, J. M. Familial spastic paraplegia with distal muscle wasting in the Old Order Amish: atypical Troyer syndrome or 'new' syndrome. Clin. Genet. 9: 315-323, 1976. [PubMed: 1261070] [Full Text: https://doi.org/10.1111/j.1399-0004.1976.tb01580.x]

  6. Patel, H., Cross, H., Proukakis, C., Hershberger, R., Bork, P., Ciccarelli, F. D., Patton, M. A., McKusick, V. A., Crosby, A. H. SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nature Genet. 31: 347-348, 2002. [PubMed: 12134148] [Full Text: https://doi.org/10.1038/ng937]

  7. Tawamie, H., Wohlleber, E., Uebe, S., Schmal, C., Nothen, M. M., Jamra, R. A. Recurrent null mutation in SPG20 leads to Troyer syndrome. Molec. Cell. Probes 29: 315-318, 2015. [PubMed: 26003402] [Full Text: https://doi.org/10.1016/j.mcp.2015.05.006]


Contributors:
Cassandra L. Kniffin - updated : 03/01/2018
Cassandra L. Kniffin - updated : 5/11/2016
Cassandra L. Kniffin - updated : 6/25/2010
Cassandra L. Kniffin - updated : 1/7/2009
Victor A. McKusick - updated : 7/23/2002

Creation Date:
Victor A. McKusick : 6/4/1986

Edit History:
carol : 03/06/2018
carol : 03/05/2018
ckniffin : 03/01/2018
alopez : 05/16/2016
ckniffin : 5/11/2016
alopez : 4/2/2014
wwang : 6/29/2010
ckniffin : 6/25/2010
wwang : 1/13/2009
ckniffin : 1/7/2009
ckniffin : 10/1/2008
ckniffin : 2/8/2005
carol : 9/18/2002
tkritzer : 9/11/2002
tkritzer : 9/11/2002
alopez : 8/1/2002
mgross : 7/24/2002
terry : 7/23/2002
terry : 7/23/2002
carol : 1/3/1995
mimadm : 3/12/1994
carol : 4/22/1992
supermim : 3/17/1992
carol : 3/2/1992
supermim : 3/20/1990